Australia's Integral Diagnostics slumps on HY results, estimate miss

Integral Diagnostics

26/02/2025 24:44

** Shares of Integral Diagnostics IDX.AX fall 29% to A$2.030, their lowest levels since February 20, 2024

** Stock is currently the top loser on ASX All Ordinaries Index .AORD

** The medical imaging services provider reports HY loss attributable of A$396,000 ($251,420.40), compared with a loss of A$66.8 million last year

** Co also reports HY operating NPAT of A$9.8 million, missing consensus estimate of A$11.1 million

** Expects replacement and growth capex for FY25 to be between A$60 million and A$65 million

** About 4.9 million shares change hands, 5.6 times the 30-day average of 870,753

** Stock down 28.9% YTD, including current session's moves

   ($1 = 1.5751 Australian dollars)

 (Reporting by Manasi Dasa in Bengaluru)

 ((Manasi.DasaSundeep@thomsonreuters.com;))